{"id":"W4414649692","doi":"10.1016/j.ygyno.2025.04.507","title":"Efficacy and safety of luveltamab tazevibulin in patients with recurrent platinum-resistant ovarian cancer: Results from the dose-optimization stage of the REFRαME-O1 (GOG-3086, ENGOT-79ov, and APGOT-OV9) phase II/III study","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre","funders":"","keywords":"Ovarian cancer; Stage (stratigraphy); Clinical trial; Phases of clinical research; Folate receptor; Cancer; Tumor stage","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006113662,0.000450457,0.001200816,0.000236057,0.0001429249,0.0006506462,0.0003972737,0.0004621392,0.001156368],"category_scores_gemma":[0.0008927495,0.0002244416,0.0007919536,0.0002690992,0.0003131993,0.0005158006,0.0001714139,0.001394056,0.0002751726],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000613797,"about_ca_system_score_gemma":0.0004349905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008652931,"about_ca_topic_score_gemma":0.002213698,"domain_scores_codex":[0.9997852,0.00009491347,0.0000133825,0.00003085138,0.00003441839,0.00004126789],"domain_scores_gemma":[0.999712,0.00007168957,0.00009309385,0.00002402312,0.00001739464,0.00008170328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4023967,0.006354454,0.05088263,0.001420721,0.004695784,0.0002961642,0.0002897729,0.004376314,0.04866665,0.0004119173,0.005173244,0.4750356],"study_design_scores_gemma":[0.3624445,0.2363607,0.3564315,0.0003463379,0.005654237,0.001860512,0.0003383224,0.008213528,0.01324089,0.0009435621,0.01403098,0.0001347983],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900885,0.007863382,0.0001909913,0.0003389172,0.00004810322,0.0001098856,0.000368988,0.0000513488,0.0009398522],"genre_scores_gemma":[0.9951836,0.002580041,0.0002595907,0.0002951546,0.00004252912,0.00007113653,0.0008559817,0.00001858513,0.0006934381],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001200816,"threshold_uncertainty_score":0.004453421,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01603174935094445,"score_gpt":0.306201884038879,"score_spread":0.2901701346879346,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}